CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits
- PMID: 30594047
- PMCID: PMC6405315
- DOI: 10.1016/j.neurobiolaging.2018.11.023
CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits
Abstract
Reactive astrogliosis and early synaptic degeneration are 2 characteristic hallmarks in Alzheimer's disease (AD) brains, but a direct link between the 2 events has not been established. Here, we show that cancerous inhibitor of PP2A (CIP2A), a cancerous protein with high expression level in astrocytes, is upregulated in patients with AD and 3xTg-AD transgenic mice. Overexpression of CIP2A in astrocytes through adeno-associated virus infection both in cultured cells and in mice brains results in activation of astrocytes, increased production of cytokines and Aβ, and synaptic degeneration indicated by decreased levels of synaptic proteins, spine loss, and impairment in long-term potentiation. As a result of synaptic degeneration, CIP2A overexpression in astrocytes in vivo induces significant deficits in visual episodic memory detected by novel objective recognition test and spatial memory detected by Morris water maze. We conclude that CIP2A-promoted astrogliosis induces synaptic degeneration and cognitive deficits in AD.
Keywords: CIP2A; Cognitive deficit; Reactive astrogliosis; Synaptic degeneration.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure statement
The authors have declared that no conflict of interest exists.
Figures







Similar articles
-
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.Cell Rep. 2018 Jul 17;24(3):713-723. doi: 10.1016/j.celrep.2018.06.009. Cell Rep. 2018. PMID: 30021167 Free PMC article.
-
ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease.FASEB J. 2022 Mar;36(3):e22209. doi: 10.1096/fj.202101625R. FASEB J. 2022. PMID: 35195302
-
Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice.FASEB J. 2020 Dec;34(12):16414-16431. doi: 10.1096/fj.202001499R. Epub 2020 Oct 18. FASEB J. 2020. PMID: 33070372
-
[Alzheimer's disease, amyloid peptide and synaptic dysfunction].Med Sci (Paris). 2011 Aug-Sep;27(8-9):733-6. doi: 10.1051/medsci/2011278015. Epub 2011 Aug 31. Med Sci (Paris). 2011. PMID: 21880261 Review. French.
-
Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.Glia. 2021 Aug;69(8):1852-1881. doi: 10.1002/glia.23981. Epub 2021 Feb 25. Glia. 2021. PMID: 33634529 Free PMC article. Review.
Cited by
-
From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer.Front Genet. 2023 Feb 24;14:1110656. doi: 10.3389/fgene.2023.1110656. eCollection 2023. Front Genet. 2023. PMID: 36911405 Free PMC article. Review.
-
Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia.Mol Neurobiol. 2021 Apr;58(4):1312-1329. doi: 10.1007/s12035-020-02191-y. Epub 2020 Nov 9. Mol Neurobiol. 2021. PMID: 33169333
-
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A.Nat Commun. 2023 Feb 28;14(1):1143. doi: 10.1038/s41467-023-36693-9. Nat Commun. 2023. PMID: 36854761 Free PMC article.
-
The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review.Front Cell Neurosci. 2022 Jun 16;16:899251. doi: 10.3389/fncel.2022.899251. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35783099 Free PMC article.
-
Astrocytes: News about Brain Health and Diseases.Biomedicines. 2020 Oct 6;8(10):394. doi: 10.3390/biomedicines8100394. Biomedicines. 2020. PMID: 33036256 Free PMC article. Review.
References
-
- Akama KT, Van Eldik LJ, 2000. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNF alpha)-dependent, and involves a TNF alpha receptor-associated factor- and NF kappa B-inducing kinase-dependent signaling mechanism. J. Biol. Chem 275, 7918–7924. - PubMed
-
- Birch AM, 2014. The contribution of astrocytes to Alzheimer’s disease. Biochem. Soc. Trans 42, 1316–1320. - PubMed
-
- Braak H, Braak E, 1992. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci. Res 15, 6–31. - PubMed
-
- Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A, 2012. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J. Nucl. Med 53, 37–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials